Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
CAR T Cell Therapy Market, By Targeted Antigen (CD19, BCMA, HER2, GD2, CD20, CD22, CD30, CD33, HER1, Others (CLDN18, etc.)), By Therapeutic Application (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Glioblastoma, Sarcoma, Neuroblastoma, Acute Myeloid Leukemia, Breast Cancer, Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Glioblastoma, Sarcoma, Neuroblastoma, Acute Myeloid Leukemia, Breast Cancer, Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle ... Read More
-
Head and Neck Cancer Diagnostics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... 2022-2027. The COVID-19 pandemic has affected the healthcare systems globally and also had a significant impact on the head and neck cancer diagnosis market. As per the article published in Cancer Connect 2020, doctors from ... Read More
-
Colorectal Cancer Screening Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... of 7.45% during the forecast period. The COVID-19 pandemic had a significant impact on the market. Many countries were in lockdown and suspended trade with other countries, leading to a decline in healthcare services, including ... Read More
-
Middle East and Africa (Mea) Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... to grow with a CAGR of 5.2% over the forecast period. The market will show rapid growth due to the rising number of kidney cancer cases in the region and the increasing R&D expenditure of ... Read More
-
Global Radiation Oncology Market 2023-2027
... on the radiation oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the ... Read More
-
Europe Colorectal Cancer Screening Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... growing burden of colorectal cancer, and increasing cancer prevention initiatives. According to the WHO (World Health Organization), in Europe, colorectal cancer is considered the second-most common cause of cancer death in men and women. It ... Read More
-
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Re
... immunotherapy drugs market size reached US$ 195.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 327.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2023-2028. Immunotherapy drugs ... Read More
-
Point of Care Molecular Diagnostics Market Size by Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B, COVID-19}, Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 Point of Care Molecular Diagnostics Market is anticipated to register growth through ... Read More
-
Oncolytic Virus Therapies Market by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2023-2028
... size reached US$ 130.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 492.6 Million by 2028, exhibiting a growth rate (CAGR) of 20.90% during 2023-2028. Oncolytic virus therapies are a ... Read More
-
Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), COVID-19 Impact ... Read More
-
Global Kidney Cancer Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Kidney Cancer sales for 2023 through 2029. With Kidney Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Active Pharmaceutical Ingredients Market Size By Therapeutic Category (Oncology, Infectious Diseases, Anti-Diabetics, CNS & Anesthesia, Cardiovascular Diseases Biologics), By Synthesis (Chemical Based API, Biological API, Highly Potent API (HPAPI)), By Contract Outsourcing (CDMO, CMO), By Application (Humans, Veterinary), By Drug (Prescription, OTC), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032
... Application (Humans, Veterinary), By Drug (Prescription, OTC), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032 Global Active Pharmaceutical Ingredients Market is poised to grow significantly between 2023 and ... Read More
-
Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027
... common form of liver cancer and accounts for ~90% of cases. HCC is particularly aggressive and has a poor survival rate (five-year survival Arizton estimates that the prevalence of hepatocellular carcinoma will be high in ... Read More
-
Global Follicular Lymphoma Drugs Market Growth (Status and Outlook) 2023-2029
... of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc. LPI (LP Information)' newest research report, the “Follicular Lymphoma Drugs Industry Forecast” ... Read More
-
Global Checkpoint Inhibitors for Treating Cancer Market Growth 2023-2029
... and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and ... Read More
-
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2023-2029
... from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with ... Read More
-
Global In-Vitro Colorectal Cancer Screening Tests Market Growth (Status and Outlook) 2023-2029
... “In-Vitro Colorectal Cancer Screening Tests Industry Forecast” looks at past sales and reviews total world In-Vitro Colorectal Cancer Screening Tests sales in 2022, providing a comprehensive analysis by region and market sector of projected In-Vitro ... Read More
-
Global Basal Cell Carcinoma Treatment Market - 2023-2030
... 2030, growing at a CAGR of 9.4% during the forecast period (2023-2030). Basal cell carcinoma (BCC) is a type of skin cancer. Basal cells, a type of skin cell that creates new skin cells as ... Read More
-
Acute Myeloid Leukemia (AML) - Drug Pipeline Landscape, 2023
... leukemia (CLL), and chronic myeloid leukemia (CML). AML is the most common type of leukemia in adults, accounting for about 80% of all cases. Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) is a type of ... Read More
-
In Vitro Diagnostics Market by Product and Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Infectious Disease), End User (Hospitals, Clinics) - Forecast to 2027
... to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6%. The growing adoption of point-of-care devices and rapid tests for early disease diagnosis, and the rising government ... Read More
-
2023 Czech Republic Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... other published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 460,000 diagnosed incident cases of bladder cancer across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of bladder cancer, mostly checkpoint inhibitors. The bladder cancer ... Read More
-
Global Cancer Minimal Residual Disease Testing Market Growth 2023-2029
... result means that disease was still detected after treatment. An MRD negative result means that no disease was detected after treatment. LPI (LP Information)' newest research report, the “Cancer Minimal Residual Disease Testing Industry Forecast” ... Read More
-
Global Checkpoint Inhibitor Refractory Cancer Market Growth (Status and Outlook) 2023-2029
... Cancer sales in 2022, providing a comprehensive analysis by region and market sector of projected Checkpoint Inhibitor Refractory Cancer sales for 2023 through 2029. With Checkpoint Inhibitor Refractory Cancer sales broken down by region, market ... Read More
-
Ovarian Cancer - Drug Pipeline Landscape, 2023
... on the origination in cell types which are epithelial ovarian cancer, stromal tumor and germ cell tumor. The exact cause of Ovarian cancer is still unclear but the risk factors include family history of ovarian/breast ... Read More
Research Assistance
